News & Events
August 21, 2020
C-Path’s PKDOC and The PKD Foundation Set to Collaborate Once Again
Polycystic Kidney Disease (PKD) is an inherited disorder in which clusters of cysts develop in the kidneys. There are more than 200,000 US cases diagnosed each year and many people with this condition have kidney failure by age 60. To meet the challenge in discovering treatments for PKD, C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) is excited to announce a collaboration with The PKD Foundation, who’s mission is to fund research, advocate for patients and build a community for all impacted by PKD. The agreement renews the significant collaboration between C-Path and The PKD Foundation to facilitate existing and new mutually agreed upon programs to accelerate the pace and reduce the cost of medical product development for the diagnosis and treatment of PKD. Learn more about PKDOC.
September 7, 2011
Pharsight to Work with Critical Path Institute’s Polycystic Kidney Disease Consortium on Disease Progression ModelingPharsight, a market-leading provider of software and scientific consulting services to improve productivity and decisionmaking in clinical drug development, has announced they will be working with Critical Path Institute’s Polycystic Kidney Disease (PKD) Consortium to create and study quantitative models of disease progression in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)....